Oral administration of the immunodominant B-chain of insulin reduces diabetes in a Co-transfer model of diabetes in the NOD mouse and is associated with a switch from Th1 to Th2 cytokines

Journal of Autoimmunity

Volumn 10, Issue 4, 1997, Pages 339-346

  Polanski, Malu ^a   Melican, Nancy S ^a   Zhang, Jenny ^a   Weiner, Howard L ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Diabetes; Insulin; NOD; Oral tolerance; Th2

Indexed keywords

CYTOKINE; INSULIN DERIVATIVE; INTERLEUKIN 10; INTERLEUKIN 4; TRANSFORMING GROWTH FACTOR BETA;

ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; INSULIN TREATMENT; LYMPH NODE CELL; MALE; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

EID: 0031214341     PISSN: 08968411     EISSN: None     Source Type: Journal    
DOI: 10.1006/jaut.1997.0148     Document Type: Article

References (42)

1. Gepts W. Pathologic anatomy of the pancreas in juvenile diabetes mellitus. Diabetes. 14:1965;619-633.
2. Castaño L., Eisenbarth G.S. Type I-diabetes: a chronic autoimmune disease of human, mouse, and rat. Ann. Rev. Immunol. 8:1990;647-679.
3. Barnett A.H., Eff C., Leslie R.D.G., Pyke D.A. Diabetes in identical twins: a study of 200 pairs. Diabetologia. 20:1981;87-93.
4. Foulis A.K., Farguharson M.A., Meager A. Immunoreactive alpha-interferon in insulin-secreting beta cells on type I diabetes mellitus. Lancet. 2:1987;1423-1427.
5. Palmer J.P., McCulloch D.K. Prediction and prevention of IDDM. Diabetes. 40:1991;943-947.
6. Skyler J.S., Marks J.B. Immune intervention in type 1 diabetes mellitus. Diabetes Rev. 1:1993;15-42.
7. Wells H.G. Studies on the chemistry of anaphylaxis (III). Experiments with isolated proteins, especially those of the hen's egg. J. Infect. Dis. 8:1911;147-171.
8. Chase M. Inhibition of experimental drug allergy by prior feeding of the sensitizing agent. Proc. Soc. Exp. Biol. Med. 61:1946;257-259.
9. Mowat A.M. The regulation of immune responses to dietary protein antigens. Immunol. Today. 8:1987;93-98.
10. Weiner H.L., Freidman A., Miller A., Khoury S.J., Al-Sabbagh A., Santos L., Sayegh M., Nussenblatt R.B., Trentham D.E., Hafler D.A. Oral tolerance: immunologic mechanisms and treatment of animal and human organ specific autoimmune diseases by oral administration of autoantigens. Ann. Rev. Immunol. 12:1994;809-837.
11. Higgins P.J., Weiner H.L. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein and its fragments. J. Immunol. 140:1988;440-445.
12. Nussenblatt R.B., Caspi R.R., Mahdi R., Chan C.-C., Roberge F., Lider O., Weiner H.L. Inhibition of S-antigen induced experimental autoimmune uveoretinitis by oral induction of tolerance with S-antigen. J. Immunol. 144:1990;1689-1695.
13. Nagler-Anderson C., Bober L.A., Robinson E.M., Siskind G.W., Thorbecke J.F. Suppression of type II collagen-induced arthritis by intragastric administration of soluble type II collagen. Proc. Natl. Acad. Sci. USA. 83:1986;7443-7446.
14. Zhang Z.J., Davidson L., Eisenbarth G., Weiner H.L. Suppression of diabetes in nonobese diabetic mice by oral administration of porcine insulin. Proc. Natl. Acad. Sci. USA. 88:1991;10252-10256.
15. +. J. Autoimmun. 7:1994;655-663.
16. Miller A., Lider O., Weiner H.L. Antigen-driven bystander suppression following oral administration of antigens. J. Exp. Med. 174:1991;791-798.
17. Harrison L. Islet cell antigens in insulin-dependent diabetes: Pandora's box revisited. Immunol. Today. 13:1992;348-352.
18. Makino S., Kunimoto D., Muraoka Y., Mizushima Y., Katagiri K., Tochino Y. Breeding of non-obese, diabetic strain of mice. Exp. Animal. 29:1980;1-13.
19. Sadelain M.W.J., Qin H.-Y., Lauzon J., Singh B. Prevention of type I diabetes in NOD mice by adjuvant immunotherapy. Diabetes. 39:1990;583-589.
20. Rapoport M.J., Jaramillo A., Zipris D., Lazarus A.H., Serreze D.V., Leiter E.H., Cyopick P., Danska J.S., Delovitch T.L. Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice. J. Exp. Med. 178:1993;87-99.
21. Lund T., O'Reilly L., Hutchings P., Kanagawa O., Simpson E., Gravely R., Chandler P., Dyson J., Picard J.K., Edwards A., Kioussis D., Cooke A. Prevention of insulin-dependent diabetes mellitus in non-obese diabetic mice by transgenes encoding modified I-A β-chain or normal I-E α-chain. Nature. 345:1990;727-729.
22. Hancock W.W., Polanski M., Zhang J., Blogg N., Weiner H. Suppression of insulitis in non-obese diabetic (NOD) mice by oral insulin administration is associated with selective expression of interleukin-4 and 10, transforming growth factor-β, and prostaglandin-E. Amer. J. Path. 147:1995;1193-1199.
23. Daniel D., Gill R.G., Schloot N., Wegmann D. Epitope specificity, cytokine production profile and diabetogenic activity of insulin-specific T cell clones isolated from NOD mice. Eur. J. Immunol. 25:1995;1056-1062.
24. Wicker L.S., Miller B.J., Mullen Y. Transfer of autoimmune diabetes mellitus with splenocytes from nonobese diabetic (NOD) mice. Diabetes. 35:1986;855-860.
25. Melamed D., Friedman A. Modification of the immune response by oral tolerance: antigen requirements and interaction with immunogenic stimuli. Cell. Immunol. 146:1993;412-420.
26. Strobel S., Ferguson A. Persistence of oral tolerance in mice fed ovalbumin is different for humoral and cell-mediated immune responses. Immunology. 60:1987;317-318.
27. Boitard C., Yasunami R., Dardenne M., Bach J.F. T cell mediated inhibition of the transfer of autoimmune diabetes in NOD mice. J. Exp. Med. 169:1989;1669-1680.
28. Sempé P., Richard M.-F., Bach J.-F., Boitard C. Evidence of CD4+ regulatory T cells in the non-obese diabetic male mouse. Diabetologia. 37:1994;337-343.
29. Liblau R.S., Singer S.M., McDevitt H.O. Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol. Today. 16:1995;34-38.
30. Katz J.D., Benoist C., Mathis D. T helper cell subsets in insulin-dependent diabetes. Science. 268:1995;1185-1188.
31. Healey D., Ozegbe P., Arden S., Chandler P., Hutton J., Cooke A. In vivo activity and in vitro specificity of CD4+ Th1 and Th2 cells derived from the spleens of diabetic NOD mice. J. Clin. Invest. 95:1995;2979-2985.
32. Friedman A., Weiner H.L. Induction of anergy or active suppression following oral tolerance is determined by antigen dosage. Proc. Natl. Acad. Sci. USA. 91:1994;6688-6692.
33. Lamont A.G., Gordon M., Ferguson A. Oral tolerance in protein deprived mice. II. Evidence of normal 'gut processing' of ovalbumin, but suppressor cell deficiency, in deprived mice. Immunology. 61:1987;339-343.
34. Bruce M.G., Ferguson A. The influence of intestinal processing on the immunogenicity and molecular size of absorbed, circulating ovalbumin in mice. Immunology. 59:1986;295-300.
35. Holt P.G., Vines J., Britten D. Suppression of IgE responses by antigen inhalation: failure of tolerance mechanism(s) in newborn rats. Immunology. 63:1988;591-593.
36. Pennline K.J., Roque-Gaffney E., Monahan M. Recombinant human IL-10 prevents the onset of diabetes in the nonobese diabetic mouse. Clin. Immunol. Immunopathol. 71:1994;169-175.
37. Wogensen L., Lee M.-S., Sarvetnick N. Production of interleukin 10 by islet cells accelerates immune-mediated destruction of β cells in nonobese diabetic mice. J. Exp. Med. 179:1994;1379-1384.
38. Shehadeh N.N., LaRosa F., Lafferty K. Altered cytokine activity in adjuvant inhibition of autoimmune diabetes. J. Autoimmun. 6:1993;291-300.
39. Tisch R., Yang X.-D., Singer S.M., Liblau R.S., Fugger L., McDevitt H.O. Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice. Nature. 366:1993;72-75.
40. Kaufman D.L., Clare-Salzler M., Tian J., Forsthuber T., Ting G.S.P., Robinson P., Atkinson M.A., Sercarz E.E., Tobin A.J., Lehmann P.V. Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature. 366:1993;69-72.
41. Rabinovitch A., Suarez-Pinzon W.L., Sorensen O., Bleackley R.C., Power R.F. IFN-γ gene expression in pancreatic islet-infiltrating mononuclear cells correlates with autoimmune diabetes in nonobese diabetic mice. J. Immunol. 154:1995;4874-4882.
42. Muir A., Peck A., Clare-Salzler M., Song Y.H., Cornelius J., Luchetta R., Krischer J., Maclaren N. Insulin immunization of nonobese diabetic mice induces a protective insulitis characterized by diminished intraislet interferon gamma transcription. J. Clin. Invest. 95:1995;628-634.